Cargando…
Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs
Many bacteria use CRISPR–Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids(1). In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity(2,3). Here we unveil a distinct type of CRISPR–Cas Inhibition strategy that is based on small non-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651486/ https://www.ncbi.nlm.nih.gov/pubmed/37853129 http://dx.doi.org/10.1038/s41586-023-06612-5 |
Sumario: | Many bacteria use CRISPR–Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids(1). In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity(2,3). Here we unveil a distinct type of CRISPR–Cas Inhibition strategy that is based on small non-coding RNA anti-CRISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units(4). We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR–Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR–Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes(5). Functional testing of nine candidates spanning the two CRISPR–Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications(6). |
---|